300142 沃森生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)1.7101.5144.5508.2955.692
总资产报酬率 ROA (%)1.1680.9382.7125.0233.670
投入资产回报率 ROIC (%)1.6181.3914.1787.8035.471

边际利润分析
销售毛利率 (%)71.69479.69185.47488.01888.612
营业利润率 (%)8.1663.42614.92521.61520.511
息税前利润/营业总收入 (%)4.3314.51812.83519.80719.355
净利润/营业总收入 (%)6.0226.18112.43018.44617.366

收益指标分析
经营活动净收益/利润总额(%)169.145156.999160.534119.595117.808
价值变动净收益/利润总额(%)69.405-50.576-38.004-17.519-31.436
营业外收支净额/利润总额(%)-2.99047.603-2.503-2.707-0.188

偿债能力分析
流动比率 (X)3.5232.9822.7262.5502.374
速动比率 (X)3.1982.6642.4032.2662.104
资产负债率 (%)17.42121.84426.90128.34026.878
带息债务/全部投入资本 (%)0.2422.5894.1201.4260.063
股东权益/带息债务 (%)39,655.9743,603.8792,196.5716,535.940151,499.450
股东权益/负债合计 (%)419.431293.166222.946209.008230.844
利息保障倍数 (X)-1.204-2.236-7.437-15.997-17.309

营运能力分析
应收账款周转天数 (天)368.646351.538292.173214.357233.085
存货周转天数 (天)360.051561.439611.627552.109619.485